SCHEMBL2359779

SCHEMBL2359779

Cc1ccc(S(=O)(=O)n2ccc3nc(CNC(N)=O)cnc32)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.45
NOD1 Q9Y239 2/20 0.36
POLB P06746 1/20 0.36
ALDH3A1 P30838 1/20 0.36
HTT P42858 1/20 0.36
ENPP3 O14638 1/20 0.36
ENPP1 P22413 1/20 0.36
SLC1A3 P43003 1/20 0.36
SLC1A2 P43004 1/20 0.36
SLC1A1 P43005 1/20 0.36
RAB9A P51151 2/20 0.35
BRD4 O60885 1/20 0.35
RAPGEF4 Q8WZA2 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
GBA1 P04062 1/20 0.34
KLKB1 P03952 1/20 0.34
HDAC3 O15379 2/20 0.34
HDAC4 P56524 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC7 Q8WUI4 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2318672 0.91 L3MBTL1 (0.46) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL18855846 0.85 L3MBTL1 (0.49) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL12389611 0.85 CA12 (0.42) L3MBTL1POLBBRD4
SCHEMBL20684438 0.84 L3MBTL1 (0.48) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL1536085 0.83 HPGD (0.47) POLBNPSR1
SCHEMBL1934188 0.83 L3MBTL1 (0.51) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL1536777 0.83 L3MBTL1 (0.51) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL2317967 0.83 L3MBTL1 (0.46) L3MBTL1NOD1POLBALDH3A1HTT
Hydrochloric Acid SCHEMBL1536094 0.82 L3MBTL1 (0.50) L3MBTL1NOD1POLBALDH3A1HTT
SCHEMBL18855958 0.82 L3MBTL1 (0.46) L3MBTL1NOD1POLBALDH3A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS ABBVIE INC. (US) 2014-11-27 US disclosed
US-8785639-B2 Substituted dihydropyrazolo[3,4-D]pyrrolo[2,3-B]pyridines and methods of use thereof ABBVIE INC. (US) 2014-07-22 US disclosed
CN-102711470-A Novel tricyclic compounds ABBOTT LAB 2012-10-03 CN disclosed
US-20110190489-A1 Novel Tricyclic Compounds ABBOTT LABORATORIES (US) 2011-08-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140349970-A1 NOVEL TRICYCLIC COMPOUNDS CCNI, IL2, IL4I1 L3MBTL1 4805/4885NOD1 457/4885POLB 2384/4885
US-20110190489-A1 Novel Tricyclic Compounds CCNI, IL2, IL4I1 L3MBTL1 4805/4885NOD1 457/4885POLB 2384/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.